ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2023 Earnings Call Transcript November 8, 2023
ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.01.
Operator: Good afternoon, and welcome to the ADMA Biologics Third Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, November 8, 2023. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call...
